logo
Prospera Energy Announces Acquisition of White Tundra Petroleum, Operations Update, and Convertible Debt Repayment Terms

Prospera Energy Announces Acquisition of White Tundra Petroleum, Operations Update, and Convertible Debt Repayment Terms

Yahoo07-03-2025
CALGARY, Alberta, March 06, 2025 (GLOBE NEWSWIRE) -- Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) ("Prospera", 'PEI' or the "Corporation")
White Tundra Acquisition Prospera Energy is pleased to announce a strategic acquisition aimed at expanding its asset portfolio of low-decline base production with significant production upside. The Corporation has entered into an agreement to acquire 100% of the issued and outstanding common shares of White Tundra Petroleum ('WTP'). WTP's assets produce 30° API medium oil and are located near Loyalist and Hanna, Alberta. The acquisition strengthens PEI's base production and provides numerous high-impact reactivation opportunities. This transaction is subject to TSXV acceptance.
As part of the transaction, 18,000,000 common shares of PEI will be issued to WTP shareholders, contingent upon WTP achieving 85 barrels of oil equivalent per day (boe/d) for three consecutive days across its properties. This condition was achieved based on production levels from February 27th to March 1st. A performance-based bonus of 7,312,500 additional shares will be issued if production of 128 boe/d can be demonstrated for at least seven consecutive days within six months from the acquisition date. The Corporation is also assuming $695,000 in debt as part of the transaction.
Prospera will assume operational oversight of WTP on March 6th, 2025, and immediately deploy a $200,000 workover and reactivation program to optimize production beyond 128 boe/d. The bonus share consideration will be issued following the final statement of adjustments and verification of sustained production levels.
This transaction qualifies as a related party transaction. Shubham Garg serves as Prospera's Chairman of the Board, the CEO of WTP, and is a shareholder of WTP. The Corporation has relied on the exemptions from the valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(a) and 5.7(a) of MI 61-101 in respect of such insider participation. In addition, the related party director has recused himself from all board discussions including the acquisition's deal structure, valuation, and decisions in relation to this transaction.
The Corporation has strengthened its corporate governance policies, including full public disclosure of monthly operational updates. These policies are now transparently available on Prospera's website which include the PEI board mandate, PEI audit committee charter, PEI disclosure policy, ESTMA reports, and PEI related parties policies. This highlights Prospera's renewed commitment to enhanced transparency, public disclosure, and governance.
Operations Update:
Following the February operations update, PEI production continues to increase, exiting February at 878 boe/d (94% oil) which is up 10% from the previously reported February PEI peak production. On March 3rd, Luseland production reached 130 boe/d (100% oil), the highest since December 2023, while Hearts Hill achieved 208 boe/d (86% oil), marking the field's highest production since November 2019. These milestones reflect the Corporation's renewed strategic focus on high certainty, low-cost workovers rather than development drilling programs. The Corporation's two active service rigs are continuing to bring wells online across its Luseland and Hearts Hill properties.
Convertible DebtProspera is pleased to announce that it has reached a settlement agreement with its convertible debt holders to address the upcoming maturity of its $1,500,000 convertible debt, along with accrued interest of $559,374.82 as of the note maturity date on March 26th, 2025.
Under the terms of the agreement:
The $1,500,000 principal will be refinanced through the issuance of a 12-month promissory note bearing 12% interest, with monthly principal repayments of $250,000 commencing six months after issuance. Interest will be paid as a balloon payment at the end of the term.
$200,000 of outstanding interest will be settled through a 12-month convertible note at 12% interest, convertible into PEI common shares at $0.05 per share. Prospera retains the right to pay this note in cash by providing thirty days notice, during which the holder retains the right to convert.
The remaining $359,374.82 in accrued interest will be settled through a shares-for-debt agreement at $0.04 per share, subject to TSXV acceptance.
The convertible debt settlement reduces Prospera's total fully diluted share count by 30,000,000 common shares, resulting in a net reduction of (17,015,630) shares to Prospera's fully diluted scenario after accounting for the shares for debt and convertible debt transactions. PEI's capitalization table is available in its corporate deck at ProsperaEnergy.com.
About Prospera Prospera Energy Inc. is a publicly traded Canadian energy company specializing in the exploration, development, and production of crude oil and natural gas. Headquartered in Calgary, Alberta, Prospera is dedicated to optimizing recovery from legacy fields using environmentally safe and efficient reservoir development methods and production practices. The company's core properties are strategically located in Saskatchewan and Alberta, including Cuthbert, Luseland, Hearts Hill, and Brooks. Prospera Energy Inc. is listed on the TSX Venture Exchange under the symbol PEI and the U.S. OTC Market under GXRFF.
Prospera reports gross production at the first point of sale, excluding gas used in operations and volumes from partners in arrears, even if cash proceeds are received. Gross production represents Prospera's working interest before royalties, while net production reflects its working interest after royalty deductions. These definitions align with ASC 51-324 to ensure consistency and transparency in reporting.
For Further Information:
Shawn Mehler, PR Email: investors@prosperaenergy.com
Chris Ludtke, CFOEmail: cludtke@prosperaenergy.com
Shubham Garg, Chairman of the BoardEmail: sgarg@prosperaenergy.com
FORWARD-LOOKING STATEMENTSThis news release contains forward-looking statements relating to the future operations of the Corporation and other statements that are not historical facts. Forward-looking statements are often identified by terms such as 'will,' 'may,' 'should,' 'anticipate,' 'expects' and similar expressions. All statements other than statements of historical fact included in this release, including, without limitation, statements regarding future plans and objectives of the Corporation, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.
Although Prospera believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because Prospera can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, risks associated with the oil and gas industry in general (e.g., operational risks in development, exploration and production; delays or changes in plans with respect to exploration or development projects or capital expenditures; the uncertainty of reserve estimates; the uncertainty of estimates and projections relating to production, costs and expenses, and health, safety and environmental risks), commodity price and exchange rate fluctuations and uncertainties resulting from potential delays or changes in plans with respect to exploration or development projects or capital expenditures.
The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Prospera. As a result, Prospera cannot guarantee that any forward-looking statement will materialize, and the reader is cautioned not to place undue reliance on any forward- looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release, and Prospera does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by Canadian securities law.
Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

MS initiates coverage on AI Biotechs, flags key pipeline catalysts
MS initiates coverage on AI Biotechs, flags key pipeline catalysts

Yahoo

timean hour ago

  • Yahoo

MS initiates coverage on AI Biotechs, flags key pipeline catalysts

-- Morgan Stanley initiated coverage on three AI-integrated biotechnology firms, Absci, Schrodinger (NASDAQ:SDGR), and Recursion Pharmaceuticals, flagging divergent business models and upcoming catalysts in a sector under pressure. The brokerage rated Absci 'overweight' with a $7 price target, and assigned 'equal weight' ratings to Schrodinger and Recursion with price targets of $28 and $5, respectively. Absci combines generative AI with lab validation through its Integrated Drug Creation Platform. Its lead candidate, ABS-101, is a TL1A monoclonal antibody in Phase I for inflammatory bowel disease. Interim data from this trial, expected in 2H25, is being closely watched for indicators of safety, pharmacokinetics, and immunogenicity. Absci is in discussions with three biopharma firms for potential partnerships and aims to use any resulting non-dilutive funding to extend its cash runway, currently guided through 1H27. A second candidate, ABS-201, targets androgenetic alopecia and could address a U.S. population of 80 million, representing a $7B–$14B market opportunity. A Phase I trial is planned for 2026, with a proof-of-concept readout expected in 2H26. Morgan Stanley does not yet assign financial value to this program due to its early stage. Schrodinger's model includes a software licensing segment that contributed $180 million in 2024 revenue, up 13% year-over-year, and showed 98-100% customer retention for contracts over $500K. FY25 guidance indicates expected software revenue growth of 10–15%, or about $203 million. Peak modeled contribution from the software business is $404 million by 2035, though consensus projects up to $497 million. The company's proprietary pipeline includes SGR-1505, which posted early efficacy in B-cell malignancies with 18% response in CLL/SLL and 100% in WM in a Phase I trial. No dose-limiting toxicities were reported. Additional data for SGR-1505 and two other oncology programs (SGR-2921 and SGR-3515) are expected in 2H25. Schrodinger's price target was lowered from $31 to $28 due to increasing competitive pressure in CLL. Recursion has refocused its pipeline following the discontinuation of three programs. Its lead drug, REC-4881, is in a Phase Ib/II trial for familial adenomatous polyposis. Early data showed a median 43% reduction in polyps across six patients. Further efficacy and safety results are expected later this year. Additional programs include REC-617 and REC-1245, both in early-stage trials. Recursion maintains partnerships with Bayer (OTC:BAYRY), Roche/Genentech, and Sanofi (NASDAQ:SNY), with potential economics totaling ~$20 billion. The brokerage models $840 million in risk-adjusted peak U.S. sales for REC-4881, with Street consensus at $409 million. Despite $85B+ in AI-biotech deal flow from 2019 to mid-2025, these stocks have underperformed broader biotech indices since 2023. Morgan Stanley cites valuation overhangs, volatile clinical results, and lack of near-term revenue visibility but maintains that platform innovation and partnerships may unlock longer-term value. Related articles MS initiates coverage on AI Biotechs, flags key pipeline catalysts U.S., Europe push to build critical minerals supply chains as China dominates Citi names DuPont top chemicals pick, sees earnings support from electronics, FX Sign in to access your portfolio

Arya Resources Closes Second Tranche of Flow-Through Financing
Arya Resources Closes Second Tranche of Flow-Through Financing

Yahoo

time2 hours ago

  • Yahoo

Arya Resources Closes Second Tranche of Flow-Through Financing

Vancouver, British Columbia--(Newsfile Corp. - July 3, 2025) - Arya Resources Ltd. (TSXV: RBZ) ("Arya" or the "Company") announces that, further to its news release dated June 23, 2025: It has closed its follow-on private placement (the "Second Placement") of flow-through shares, issuing 866,666 flow-through shares at a price of $0.15 per share for gross proceeds of approximately $130,000. No finder's fees were paid in connection with the Second Placement. The securities issued are subject to a hold period that expires on October 31, 2025. Insider Participation Directors and officers of the Company subscribed for a total of 433,333 flow-through shares in the Second Placement, representing approximately 1.12% of the 38,669,829 issued and outstanding common shares on closing. The insider participation in the Second Placement constitutes a "related-party transaction" under the policies of the TSX Venture Exchange and Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"), and the Company is relying upon the exemptions from the formal valuation and minority shareholder approval requirements contained in sections 5.5(a), (b) and (c), and 5.7(1)(a) and (b), respectively, of MI 61-101 on the basis that neither the fair market value of the subject matter nor of the consideration for the transaction, insofar as it involves related parties, exceeds 25% of the issuer's market capitalization; that no securities of the Company are listed or quoted on certain exchanges or markets specified in MI 61-101; and that the transaction involves a distribution of securities for cash. For the purposes of certain of those exemptions, neither the Company, nor to the knowledge of the Company after reasonable inquiry, the related parties, has knowledge of any material information concerning the Company or its securities that has not been generally disclosed. Use of Proceeds Flow-through proceeds will directly fund exploration work on Arya's Saskatchewan-based mineral projects, including its flagship Wedge Lake Gold Project, where the Company holds full permits to commence drilling as announced in its March 19, 2025, news release. Ramp East Property - Saskatchewan: Further to the news release of May 21, 2025, the Company has received Exchange acceptance for the option to acquire a 100% interest in the Ramp East Property. The Company has issued the initial 500,000 shares due under the option, which are subject to a hold period expiring October 27, 2025. The remaining payments to exercise the option are as follows: 500,000 shares on each of the dates, that is 12 months and 18 months after the Exchange approval $75,000 on the date that is 24 months after the Exchange approval The vendor will retain a 2% net smelter return (NSR) royalty, of which the Company may repurchase 1.5% NSR for $1.5 million at any time. The Ramp East Claims encompass a large portion of the gold-bearing Quartz-Diorite unit-the same host rock where Ramp Metals made its discovery. The 38,926-acre (15,753 hectares) claims are the first ground staked immediately contiguous to Ramp Metals following its announcement in June 2024. About Arya Resources Ltd. Arya Resources Ltd. (TSXV: RBZ) is a Canadian mineral exploration company focused on the discovery and development of precious and energy metals in Saskatchewan, one of Canada's most mining-friendly jurisdictions. The Company's portfolio includes gold, silver, copper, nickel, and cobalt, assets, with a focus on advancing its flagship Wedge Lake Gold Project and the Dunlop Nickel-Copper-Cobalt Project. Led by President and CEO Rasool Mohammad, Arya is committed to unlocking value through strategic exploration in stable, resource-rich regions. For further information about Arya Resources Ltd., visit us at On Behalf of the Board of Directors Rasool Mohammad, Chief Executive Officer Contact Us: Arya Resources Mohammad, CEOT: (604) 868-7737 E: rasool@ Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. This news release includes "forward-looking statements" that are subject to assumptions, risks and uncertainties. Statements in this news release which are not purely historical are forward-looking statements, including without limitation, any statements concerning the Company's intentions, plans, estimates, expectations or beliefs. Although the Company believes that any forward-looking statements in this news release are reasonable, there can be no assurance that any such forward-looking statements will prove to be accurate. The Company cautions readers that all forward-looking statements, including without limitation those relating to the Company's future operations and business prospects, are based on assumptions, none of which can be assured, and are subject to certain risks and uncertainties that could cause actual events or results to differ materially from those indicated in the forward-looking statements. Readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance on forward-looking statements. Any forward-looking statements are made as of the date of this news release, and the Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual events or results could or do differ from those projected in the forward-looking statements. Except as required by law, the Company assumes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Buscar Company and Terramer, Inc. Advance Hemp Bioplastics to Combat Microplastic Pollution
Buscar Company and Terramer, Inc. Advance Hemp Bioplastics to Combat Microplastic Pollution

Associated Press

time3 hours ago

  • Associated Press

Buscar Company and Terramer, Inc. Advance Hemp Bioplastics to Combat Microplastic Pollution

Buscar Company (OTCMKTS:CGLD) BEVERLY HILLS, CA, CA, UNITED STATES, July 3, 2025 / / -- Buscar Company (OTC: CGLD), a diversified holding company focused on sustainable energy and natural resources, today affirms its commitment to addressing the global microplastic pollution crisis through its April 11, 2025, acquisition of a 50% stake in Terramer, Inc., a leader in hemp-based bioplastics, via a strategic stock-swap transaction. This partnership advances scalable, biodegradable solutions to protect ecosystems and public health, aligning with environmental priorities championed by advocates like Minister Robert F. Kennedy Jr. However, Buscar is not directly collaborating with the U.S. government. Addressing a Global Crisis Microplastic pollution poses a severe threat to ecosystems and human health. According to a 2023 UN Environment Programme report, approximately 1.2 million metric tons of microplastics enter the oceans annually from sources such as tire wear and synthetic textiles. A 2024 study by the University of California, San Diego, estimates that individuals ingest up to 200,000 microplastic particles per year through food and water, with potential links to health risks, including inflammation and antibiotic resistance. 'Hemp bioplastics offer a sustainable path to reduce microplastic pollution,' said Alexander Dekhtyar, CEO of Buscar Company. 'Our partnership with Terramer positions us to deliver innovative solutions that protect our planet and communities.' A Strategic Partnership Buscar's investment in Terramer accelerates the development of TERBO-1000, a hemp-based bioplastic that biodegrades within 180 days, according to ASTM D6400 standards, leaving no microplastic residue. Unlike petroleum-based plastics, which can last for centuries, TERBO-1000 is free of harmful additives like BPA and is suitable for packaging, food service, and industrial uses. The partnership aims to increase production and target key markets by 2026, harnessing hemp's low-water, carbon-sequestering properties. 'Terramer's technology is a game-changer for sustainable materials,' said Alex Mond, Chairman and Founder of Terramer, Inc. 'Together with Buscar, we're driving innovation to combat microplastic pollution.' Strategically Positioned for Generating Revenue Terramer Inc. has achieved significant market traction with a strong portfolio of purchase orders and letters of intent, reflecting growing demand for its innovative TERBO-1000™️ hemp-based bioplastic products. Current purchase orders include a $6,000,000 agreement with a California-based apparel brand for hemp-based parchment papers, a $621,000 order from a national packaging distributor for food containers, a $248,000 order from an Ohio-based distribution facility for additional food containers, an order from an industrial services provider for 10,000 T-shirt bags (12'x7'x22'), and a $138,000 order from a supply company for 9x9 all-black hinged clamshell containers. Additionally, Terramer has secured letters of intent, including one with a sales group for food packaging materials valued up to $80,000,000, another with the same California apparel brand for hemp-based textiles, and a third with a global quick-service restaurant chain for assorted food packaging solutions. These commitments highlight Terramer's expanding presence in the sustainable packaging and textiles markets, positioning it to capitalize on the rapidly growing bioplastics industry. Aligned with Environmental Goals The partnership between Buscar and Terramer advances the urgent demand for eco-friendly alternatives, targeting the replacement of a significant portion of the US$185.82–226.29 billion global single-use plastics market, including US$33.03–33.48 billion in the U.S., used in food packaging, restaurants, consumer goods, and agricultural films. Their innovative hemp bioplastic products aim to replace conventional plastics in these applications, aligning with global efforts to combat plastic pollution through enhanced recycling systems and bans on harmful plastics. Robert F. Kennedy Jr., U.S. Secretary of Health and Human Services, emphasized during his speech at the Chemicals of Concern Policy Summit: 'Microplastics from food and food production assembly lines and packaging don't only end up on our food, they also contaminate our soil, our water, our oceans, and from there they re-enter the food supply!' Commitment to Sustainability Buscar and Terramer are dedicated to reducing microplastic pollution through innovative, hemp-based solutions. By advancing TERBO-1000, this partnership paves the way for a sustainable economy that prioritizes environmental and public health. About Buscar Company Buscar Company (OTC: CGLD) is a diversified holding firm focused on natural resources, sustainable technologies, and pharmaceuticals. Based in Beverly Hills, California, Buscar manages Eon Discovery Inc., which handles gold mining operations in California's Plumas National Forest; Terramer Inc., a leader in hemp-based biodegradable bioplastics; and Armorgenix, a pharmaceutical innovator specializing in detoxification and antiviral solutions. Formed through a strategic evolution, including a 2020 reverse merger with Eon Discovery, Buscar aims to drive growth and increase shareholder value through innovation and diversification. Forward-Looking Statement This press release contains forward-looking statements under Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements include, but are not limited to, projections about the growth of the hemp bioplastics market, the expected impact of the Buscar-Terramer partnership, and the development and commercialization of TERBO-1000. Such statements are based on current expectations and assumptions. They are subject to risks and uncertainties, including regulatory challenges, market acceptance, production delays, and economic conditions, which could cause actual results to differ significantly from these projections. Buscar makes no obligation to update these statements except as required by law. For a detailed discussion of risks, please refer to Buscar's filings with the Securities and Exchange Commission. Alexander Dekhtyar Buscar Company, CEO Alexander Dekhtyar Buscar Company +1 833-539-4777 email us here Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store